{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "11077584",
  "DateCompleted": {
    "Year": "2001",
    "Month": "01",
    "Day": "09"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "09",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "ger"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0009-4722",
      "JournalIssue": {
        "Volume": "71",
        "Issue": "10",
        "PubDate": {
          "Year": "2000",
          "Month": "Oct"
        }
      },
      "Title": "Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen",
      "ISOAbbreviation": "Chirurg"
    },
    "ArticleTitle": "[\"Field cancerization\"--an additional phenomenon in development of colon tumors? K-ras codon 12 mutations in normal colonic mucosa of patients with colorectal neoplasms].",
    "Pagination": {
      "StartPage": "1230",
      "EndPage": "1235",
      "MedlinePgn": "1230-4; discussion 1234-5"
    },
    "Abstract": {
      "AbstractText": [
        "The c-K-ras2-gene (K-ras) encodes the p21ras protein, which participates in the transduction of mitogenic signals from the cell surface to the nucleus. About 40-50% of colorectal cancers bear a point mutation of the K-ras codon 12 within exon I, leading to activation of the K-ras oncogene.",
        "Using a polymerase chain reaction (PCR)-based two-step restriction fragment length polymorphism (2sRFLP)-technique, we assessed the frequency of point mutations in the first or second base of K-ras codon 12 in patients suffering from colorectal carcinoma, adenoma, and their normal colon mucosa, respectively.",
        "Similar to other investigators, we found mutations in 7 out of 17 (41%) colorectal carcinomas and 1 out of 4 (25%) adenomas. Using this very sensitive 2sRFLP technique (detection level = 0.2% of mutated cells), we were able to find K-ras codon 12 mutations in normal mucosa in 4 out of 18 (22.2%) patients with colorectal neoplasia.",
        "This result can be explained by the phenomenon of \"field cancerization\" or by a local micrometastasis of K-ras-positive tumor cells."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Klinik f\u00fcr Allgemein- und Unfallchirurgie, Heinrich Heine-Universit\u00e4t D\u00fcsseldorf. alvesai@uni-duesseldorf.de"
          }
        ],
        "LastName": "Aivado",
        "ForeName": "M",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Gynes",
        "ForeName": "M",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Gorelov",
        "ForeName": "V",
        "Initials": "V"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Schmidt",
        "ForeName": "W U",
        "Initials": "WU"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "R\u00f6her",
        "ForeName": "H D",
        "Initials": "HD"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Goretzki",
        "ForeName": "P E",
        "Initials": "PE"
      }
    ],
    "PublicationTypeList": [
      "English Abstract",
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ],
    "VernacularTitle": "\"Field cancerization\"--ein zus\u00e4tzliches Ph\u00e4nomen in der Entwicklung von Colontumoren? K-ras-Codon-12-Mutationen in normaler Colonmucosa von Patienten mit colorectalen Neoplasien."
  },
  "MedlineJournalInfo": {
    "Country": "Germany",
    "MedlineTA": "Chirurg",
    "NlmUniqueID": "16140410R",
    "ISSNLinking": "0009-4722"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Codon"
    },
    {
      "RegistryNumber": "EC 3.6.5.2",
      "NameOfSubstance": "HRAS protein, human"
    },
    {
      "RegistryNumber": "EC 3.6.5.2",
      "NameOfSubstance": "Proto-Oncogene Proteins p21(ras)"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "genetics",
        "pathology"
      ],
      "DescriptorName": "Adenocarcinoma"
    },
    {
      "QualifierName": [
        "genetics",
        "pathology"
      ],
      "DescriptorName": "Adenoma"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Biopsy"
    },
    {
      "QualifierName": [
        "genetics",
        "pathology"
      ],
      "DescriptorName": "Cell Transformation, Neoplastic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Codon"
    },
    {
      "QualifierName": [
        "genetics",
        "pathology"
      ],
      "DescriptorName": "Colorectal Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Exons"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "pathology"
      ],
      "DescriptorName": "Intestinal Mucosa"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Point Mutation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Polymerase Chain Reaction"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Polymorphism, Restriction Fragment Length"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Proto-Oncogene Proteins p21(ras)"
    }
  ]
}